Menu
Your Cart

Apostle MiniGenomics Viral Total NA Isolation Kit (384 preps)

Apostle MiniGenomics Viral Total NA Isolation Kit (384 preps)
Apostle MiniGenomics Viral Total NA Isolation Kit (384 preps)
Apostle MiniGenomics Viral Total NA Isolation Kit (384 preps)
Apostle MiniGenomics Viral Total NA Isolation Kit (384 preps)
Secured Shopping
Best security features
Apostle MiniGenomics Viral Total NA Isolation Kit (384 preps)
  • For fast extraction and purification of viral nucleic acids from various kinds of biological samples collected in multiple transport media.  
  • Novel and original magnetic nanoparticle technology for nucleic acids isolation.  
  • Various sample types: swabs, saliva, blood.  
  • Optimized standardized protocol for viral total NA isolation in 30 min without heating.  
  • Compatible with multiple high-throughput automated nucleic acid extraction platforms.  
  • Please note this product is not returnable.
  • Configuration: 200uL X 384 preps (A200619-384).   
  • Cat #: A200619-384.

Documentation:

Product brochure: Apostle-COVID-19-Viral-RNA-Isolation-System.pdf

System protocol: Apostle-MiniGenomics-Viral-Total-NA-Isolation-MagTouch-protocol.pdf

Application Note: Application-Note-Apostle-Viral-RNA-Isolation-System.pdf

This links directs to an Application Note on the Apostle COVID-19 Viral RNA Extraction System, applied in the effective detection of SARS-CoV-2 in over 15 million clinical samples by our clients. 

Material Safety Data Sheet (MSDS): Apostle_MiniGenomics_Viral_Total_NA_Isolation_Fast_Kit_Material_Safety_01.pdf



Inclusion in US FDA IVD EUA - Molecular Diagnostic Tests for SARS-CoV-2

Apostle RNA extraction method is included in a US FDA EUA authorized SARS-CoV-2 molecular diagnostic test: Fulgent COVID-19 by RT-PCT Test.

More information

$843.75
Tags: COVID-19
Nature 子刊 Nature Communications 近期发表又一项高影响力国际临床研究,其中应用 Apostle 艾铂图 MiniMax 游离核酸技术。此研究包括2125名癌症患者,9种不同的癌症类型。此研究表明,应用cfDNA游离核酸技术,可以有效、高敏感度地检测早期癌症。Apostle 艾铂图 MiniMax 游离核酸技术不断在国际上得到广泛的应用,迄今,已发表、被引用 Nature 子刊 3篇 ( Nature Medicine X 2, Nature Communications X 1), Science 子刊 1 篇, PNAS 1 篇,各种临床研究50余篇等。 祝贺此临床研究团队!期待Apostle 艾铂图技术更好地为人类做贡献。